NAFLD patients have been shown to have higher levels of alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transpeptidase (γ-GTP) (10). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.